Oakmont Corp’s Tectonic Therapeutic TECX Stock Holding History

Oakmont Corp’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,115	Closed	-$445K	–	32
2025 Q1	$445K	Buy	+25,115	New	+$819K	0.09%	15

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Oakmont Corp's TECX Position: Q2 2025 in Review

Oakmont Corp sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 25,115 shares — an estimated $445K sold.

Oakmont Corp first reported a position in TECX in Q1 2025 and held it in 1 quarter. The position peaked at $445K in Q1 2025. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

Oakmont Corp reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
Oakmont Corp sold 25,115 Tectonic Therapeutic shares in Q2 2025, an estimated $445K.
Oakmont Corp first reported a position in Tectonic Therapeutic in Q1 2025 and held it in 1 quarter.
Oakmont Corp's Tectonic Therapeutic position peaked at $445K in Q1 2025.
82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Oakmont Corp's 13F filing for Q2 2025, filed 17 Jul 2025.